John: Executives to Blame

[Anonymous]

“Our executives are taking too long, we're earning too much, and we're producing far too little," Lechleiter told the audience at a recent keynote speech before The Economist’s 2011 Pharma Summit in London. “Even as we rebuild our R&D engine, we must build an environment where pharmaceutical innovation can thrive."

 

[Anonymous]

“Our executives are taking too long, we're earning too much, and we're producing far too little," Lechleiter told the audience at a recent keynote speech before The Economist’s 2011 Pharma Summit in London. “Even as we rebuild our R&D engine, we must build an environment where pharmaceutical innovation can thrive."

"The rotund American CEO then awoke from his fever-dream and, to the delight of the assembled panel, flung his own ƒœces at them while shouting:'FIPNet...turn to the left...FIPNet...turn to the right.' He is now in stable condition after ECT and a Seroquel/Symbyax bolus."

 

[Anonymous]

"The rotund American CEO then awoke from his fever-dream and, to the delight of the assembled panel, flung his own ƒœces at them while shouting:'FIPNet...turn to the left...FIPNet...turn to the right.' He is now in stable condition after ECT and a Seroquel/Symbyax bolus."

Henceforth he has been pronounced as in "stable condition" although four orderlies must assist him hourly in evacuating his bowels from years of self-indulgence.